EPISODE · Apr 29, 2026
U.S. Supreme Court Hikma Pharmaceuticals v. Amarin Pharma, Case No. 24-889
from Audio Arguendo · host U.S. Supreme Court
Administrative Law: When a generic drug label fully carves out a patented use, are allegations that the generic drugmaker calls its product a "generic version" and cites public information about the branded drug enough to plead induced infringement of the patented use? - Argued: Wed, 29 Apr 2026 13:44:54 EDT
Embed this episode
NOW PLAYING
U.S. Supreme Court Hikma Pharmaceuticals v. Amarin Pharma, Case No. 24-889
0:00
0:00
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
When was this Audio Arguendo episode published?
This episode was published on April 29, 2026.
Can I download this Audio Arguendo episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!